European Respiratory Review

Papers
(The H4-Index of European Respiratory Review is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
The role of telemonitoring in patients on home mechanical ventilation257
Reply to: “Nicotine or tobacco abstinence?”188
European Respiratory Review, list of peer reviewers 2022177
Lost in translation: a neglected mTOR target for lymphangioleiomyomatosis124
Ventilation/perfusion mismatch is not the sole reason for hypoxaemia in early stage COVID-19 patients122
Health disparities and associated social determinants of health in interstitial lung disease: a narrative review120
Cough monitoring systems in adults with chronic respiratory diseases: a systematic review112
European Respiratory Review, list of peer reviewers 2023103
Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension100
Exacerbations of bronchiectasis87
ERS/EAACI statement on adherence to international adult asthma guidelines85
Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections81
Association of preserved ratio impaired spirometry with mortality: a systematic review and meta-analysis80
The re-emerging role of linoleic acid in paediatric asthma77
Epidemiology of severe asthma in children: a systematic review and meta-analysis76
Air pollution as an early determinant of COPD76
Lung stem cells and respiratory epithelial chimerism in transplantation70
Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell67
Multiple breath washout and oscillometry after allogenic HSCT: a scoping review65
Quality of life in patients with chronic respiratory failure on home mechanical ventilation64
Treatable traits in asthma during pregnancy: a call for a shift towards a precision-based management approach59
Advance care planning in patients with respiratory failure59
Global respiratory health priorities at the beginning of the 21st century59
Inhaled corticosteroids for the treatment of COVID-1958
WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension57
Diaphragm excursion and diaphragm thickening fraction: commonality and conflict57
Characteristics of scores used for quantitative lung ultrasound in neonates: a systematic review56
Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis55
Sarcopenia in interstitial lung disease54
Awake prone positioning for hypoxaemic respiratory failure: past, COVID-19 and perspectives54
The ageing of people living with cystic fibrosis: what to expect now?51
Contemporary issues in the implementation of lung cancer screening51
Sex and gender in interstitial lung diseases50
Integrating asthma care guidelines into primary care electronic medical records: a review focused on Canadian knowledge translation tools49
Phenotype overlap in the natural history of asthma48
Methods to assess COPD medications adherence in healthcare databases: a systematic review47
Smoking cessation and vaccination47
Nonpharmacological interventions in COPD46
Balancing the value and risk of exercise-based therapy post-COVID-19: a narrative review46
Sensitivity and complications of thoracentesis and thoracoscopy: a meta-analysis45
Measuring pulmonary function in COPD using quantitative chest computed tomography analysis44
Pathophysiology and genomics of bronchiectasis44
Sex and gender in respiratory physiology43
0.085405111312866